Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Gainers

  • Verona Pharma (NASDAQ:VRNA) stock moved upwards by 35.8% to $9.44 during Tuesday's regular session. As of 13:30 EST, this security is trading at a volume of 32.8 million shares, making up 35311.8% of its average full-day volume over the last 100 days. The company's market cap stands at $569.8 million. As per the press release, Q2 earnings came out today.
  • eFFECTOR Therapeutics (NASDAQ:EFTR) stock increased by 34.8% to $1.21. As of 13:30 EST, this security is trading at a volume of 44.6 million shares, making up 54406.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $49.7 million.
  • Mersana Therapeutics (NASDAQ:MRSN) stock moved upwards by 31.99% to $6.93. Trading volume for this security as of 13:30 EST is 12.7 million, which is 1007.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $672.1 million. As per the news, the Q2 earnings report came out yesterday.
  • Graybug Vision (NASDAQ:GRAY) shares increased by 30.3% to $1.26. Graybug Vision's stock is trading at a volume of 10.9 million shares as of 13:30 EST. This is 3382.8% of its average full-day volume over the last 100 days. The company's market cap stands at $26.9 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) shares rose 25.34% to $4.55. The current volume of 11.5 million shares is 574.0% of Atara Biotherapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $424.9 million. The company's, Q2 earnings came out yesterday.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) stock moved upwards by 20.3% to $8.77. Trading volume for Phathom Pharmaceuticals's stock is 2.6 million as of 13:30 EST. This is 933.9% of its average full-day volume over the last 100 days. The company's market cap stands at $343.5 million.

Losers

  • Quanterix (NASDAQ:QTRX) shares fell 59.1% to $6.75 during Tuesday's regular session. As of 13:30 EST, Quanterix's stock is trading at a volume of 8.0 million, which is 2098.9% of its average full-day volume over the last 100 days. The company's market cap stands at $248.9 million. The company's, Q2 earnings came out yesterday.
  • Cormedix (NASDAQ:CRMD) shares fell 57.85% to $3.17. The current volume of 4.2 million shares is 912.6% of Cormedix's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $124.0 million.
  • Aytu BioPharma (NASDAQ:AYTU) stock decreased by 50.66% to $0.29. Trading volume for Aytu BioPharma's stock is 11.4 million as of 13:30 EST. This is 2331.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.0 million.
  • Endo International (NASDAQ:ENDP) shares fell 41.52% to $0.39. As of 13:30 EST, Endo International's stock is trading at a volume of 92.4 million, which is 189.1% of its average full-day volume over the last 100 days. The company's market cap stands at $91.8 million. The company's, Q2 earnings came out today.
  • DermTech (NASDAQ:DMTK) stock decreased by 34.1% to $5.56. The current volume of 1.7 million shares is 181.8% of DermTech's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $166.3 million. As per the news, the Q2 earnings report came out yesterday.
  • Novavax (NASDAQ:NVAX) stock declined by 30.98% to $39.52. Novavax's stock is trading at a volume of 22.6 million shares as of 13:30 EST. This is 314.5% of its average full-day volume over the last 100 days. The company's market cap stands at $3.0 billion. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.